GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nymox Pharmaceutical NYMXF · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.02

—

Close of 20 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Nymox Pharmaceutical — daily NYMXF Delayed
Market value
$1.9m
Last close × shares
Volume
1.1k
Shares, 20 Nov 2026

About Nymox Pharmaceutical

Its shares trade under the ticker NYMXF. It has been listed since 26 November 1997. In the fiscal year to 31 December 2020, it reported revenue of $10,000 and a net loss of $11.7m. At that date it held total assets of $4.3m and shareholders' equity of $2.1m.

Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. The company is headquartered in Saint-Laurent, Quebec. The firm is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The firm operates through the research and development of products for the aging population segment. The firm markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. The firm also owns rights for its marketed products, its investigational drug, as well as other therapeutic and diagnostic indications. The firm also has the rights for the use of statin drugs for the treatment and prevention of Alzheimer's disease. The firm's subsidiaries include Nymox Corporation and Serex, Inc. Nymox Corporation conducts research and development, while Serex, Inc. conducts research and development, and manufacturing of NicAlert and TobacAlert.

Figures and description from our data supplier, not checked against the company's own report.

More about Nymox Pharmaceutical →

Latest on Nymox Pharmaceutical

Our reporting

We have not reported on Nymox Pharmaceutical yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Nymox Pharmaceutical's ticker?

Nymox Pharmaceutical trades as NYMXF on its US listing, under ISIN BSP733981026.

What was Nymox Pharmaceutical's last closing price?

0.02 on 20 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.